Challenges to achieving value in drug spending in a decentralized country: the Spanish case.

@article{Antoanzas2003ChallengesTA,
  title={Challenges to achieving value in drug spending in a decentralized country: the Spanish case.},
  author={Fernando Anto{\~n}anzas},
  journal={Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research},
  year={2003},
  volume={6 Suppl 1},
  pages={S52-63}
}
OBJECTIVES This article presents an overview of the Spanish health sector variables and drug policies as well as highlights the perspectives of new reforms. METHODS Initially, the text frames the health sector in the sociodemographic context; it describes the past two decades of demographic changes noting particularly the very low birth rate and the growth in the proportion of the elderly. It also summarizes the main aggregate economic trends emphasizing the gross national product growth of… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 10 references

Incentivos a prescriptores

  • L Cabiedes, V. Ortún
  • En Puig J, ed., Análisis Económico de la…
  • 2002

Public demand for medicines, price regulation, and government-industry relationships in Spain

  • R Nonell, Borrell
  • Environ Plan C Gov Policy 2001;19:119–34
  • 2001

Prices, Competition and Regulation in Pharmaceuticals: A Cross-National Comparison

  • PM Danzon, L. Chao
  • London: Office of Health Economics,
  • 2000

La incentivación económica de los profesionales en atención primaria

  • R Cunillera
  • Incentivos y Contratos en Los Servicios de Salud
  • 1999

Mercado de medicamentos en España: diseño institucional de la regulación y de la provisión pública

  • R Nonell, Borrell
  • Papeles Econ Española
  • 1998

Regulación y competencia de precios en el mercado farmacéutico

  • J. Puig
  • Papeles Econ Española
  • 1998

Consecuencias económicas de las importaciones paralelas de medicamentos

  • F Antoñanzas, L Cabiades, J. Rovira
  • Informe CEDEF Sobre Importaciones Paralelas…
  • 1995

Incentivos para la innovación en el mercado farmacéutico

  • P Ibern

Similar Papers

Loading similar papers…